Teradyne, Inc. (NASDAQ:TER - Get Free Report) CEO Gregory Stephen Smith sold 554 shares of Teradyne stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $106.00, for a total transaction of $58,724.00. Following the transaction, the chief executive officer directly owned 96,993 shares in the company, valued at $10,281,258. This trade represents a 0.57% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Gregory Stephen Smith also recently made the following trade(s):
- On Wednesday, July 30th, Gregory Stephen Smith sold 554 shares of Teradyne stock. The stock was sold at an average price of $105.73, for a total transaction of $58,574.42.
Teradyne Trading Up 0.2%
Shares of TER stock traded up $0.21 during trading hours on Tuesday, hitting $110.62. 3,170,422 shares of the company's stock were exchanged, compared to its average volume of 4,852,161. Teradyne, Inc. has a 12-month low of $65.77 and a 12-month high of $144.16. The business's 50 day simple moving average is $96.12 and its 200-day simple moving average is $91.17. The company has a market capitalization of $17.60 billion, a PE ratio of 38.28, a PEG ratio of 2.31 and a beta of 1.72.
Teradyne (NASDAQ:TER - Get Free Report) last issued its earnings results on Tuesday, July 29th. The company reported $0.57 EPS for the quarter, topping the consensus estimate of $0.54 by $0.03. The company had revenue of $651.80 million for the quarter, compared to the consensus estimate of $649.02 million. Teradyne had a net margin of 16.59% and a return on equity of 18.16%. The firm's revenue for the quarter was down 10.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.86 earnings per share. Teradyne has set its Q3 2025 guidance at 0.690-0.870 EPS. Equities analysts anticipate that Teradyne, Inc. will post 3.88 EPS for the current year.
Teradyne announced that its board has authorized a stock repurchase plan on Monday, April 28th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the company to buy up to 8.1% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company's leadership believes its stock is undervalued.
Analyst Upgrades and Downgrades
Several analysts recently weighed in on TER shares. Cantor Fitzgerald set a $105.00 price target on shares of Teradyne and gave the company an "overweight" rating in a report on Tuesday, June 24th. JPMorgan Chase & Co. restated a "neutral" rating and set a $102.00 target price (up previously from $88.00) on shares of Teradyne in a report on Thursday, July 17th. The Goldman Sachs Group restated a "sell" rating and set a $85.00 target price on shares of Teradyne in a report on Wednesday, July 30th. Susquehanna dropped their target price on shares of Teradyne from $155.00 to $133.00 and set a "positive" rating on the stock in a report on Wednesday, April 30th. Finally, Morgan Stanley upgraded shares of Teradyne from an "underweight" rating to an "equal weight" rating and boosted their target price for the company from $74.00 to $100.00 in a report on Thursday, July 31st. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $114.44.
Check Out Our Latest Stock Analysis on Teradyne
Hedge Funds Weigh In On Teradyne
A number of hedge funds have recently bought and sold shares of TER. Berbice Capital Management LLC increased its position in shares of Teradyne by 200.0% during the 1st quarter. Berbice Capital Management LLC now owns 300 shares of the company's stock valued at $25,000 after purchasing an additional 200 shares during the last quarter. Strategic Investment Solutions Inc. IL bought a new position in shares of Teradyne during the 4th quarter valued at approximately $34,000. CYBER HORNET ETFs LLC bought a new position in shares of Teradyne during the 2nd quarter valued at approximately $35,000. Manchester Capital Management LLC grew its stake in shares of Teradyne by 44.7% during the 1st quarter. Manchester Capital Management LLC now owns 453 shares of the company's stock valued at $37,000 after acquiring an additional 140 shares during the period. Finally, Brooklyn Investment Group grew its stake in shares of Teradyne by 189.9% during the 1st quarter. Brooklyn Investment Group now owns 461 shares of the company's stock valued at $38,000 after acquiring an additional 302 shares during the period. Hedge funds and other institutional investors own 99.77% of the company's stock.
About Teradyne
(
Get Free Report)
Teradyne, Inc designs, develops, manufactures, and sells automated test systems and robotics products worldwide. It operates through four segments; Semiconductor Test, System Test, Robotics, and Wireless Test. The Semiconductor Test segment offers products and services for wafer level and device package testing of semiconductor devices in automotive, industrial, communications, consumer, smartphones, cloud, computer and electronic game, and other applications.
See Also

Before you consider Teradyne, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teradyne wasn't on the list.
While Teradyne currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.